Alumis shares fall nearly 16% in Nasdaq debut
28/06/2024 17:41
June 28 (Reuters) - Shares of biopharmaceutical firm
Alumis ALMS.O opened nearly 16% below their initial public
offering (IPO) price in their debut on the Nasdaq on Friday.
(Reporting by Niket Nishant in Bengaluru; Editing by Shinjini
Ganguli)
((Niket.Nishant@thomsonreuters.com;))
Recent news on Alumis
See all newsBrief: Alumis Says Envudeucitinib Improves Psoriasis Symptoms in Phase 3 Data
U.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Alumis set for worst day after lupus drug misses main goal in mid-stage trial
Alumis eyes late-stage lupus study despite trial miss (updated)
Alumis tumbles after lupus drug misses main goal in mid-stage trial